Tough quarter for Johnson & Johnson in the eye care market
Monday, November 3 2014 | 00 h 00 min | News
Despite a good quarter for the company in general (sales of US$18.5 billion, up by 5.1% over last year), Johnson & Johnson reported a drop in eye care product sales in the third quarter of 2014.
Johnson & Johnson gave competitive pricing as a reason for the drop in eye care product sales of 5.9%, compared with 2013. These sales were CA$786 million in the third quarter of 2014. The drop was dramatic in the United States (-12.5%) and less harsh in other markets (-2.3%).
For further information: http://www.jnj.com/news/all/Johnson-and-Johnson-Reports-2014-Third-Quarter-Results
